Related Experiment Video
Updated: Jun 5, 2026

Semi-Quantitative Analysis of Peptidoglycan by Liquid Chromatography Mass Spectrometry and Bioinformatics
Published on: October 13, 2020
A peptidoglycan monomer with the glutamine to serine change and basic peptides bind in silico to TLR-2 (403-455)
Yufeng Li1, Clay L Efferson, Rajagopal Ramesh
1Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA. yim_lee80@hotmail.com
Abstract:
Bacterial cell wall polysaccharides, such as PGN, bind and activate TLR-2, NOD2 and PGRP on monocytes/macrophages and activate inflammation. We found that the peptides containing basic amino acids (cations) at N -terminus and tyrosine at C-terminus interfered with activating ability of PGN. This finding is significant because the ECD of TLR-2 in vivo encounters a large number of proteins or peptides. Some should bind ECD and "pre-form" TLR-2 to respond or not to its activators, although they cannot activate TLR-2 alone. TLR-2 is receptor for a large number of ligands, including lipopeptides and bacterial cell wall glycoproteins. A binding site for lipopeptides has been identified; however, a binding site for soluble or multimeric PGN has not been proposed. To identify the candidate binding sites of peptides and PGN on TLR-2, we modeled docking of peptides and of the PGN monomer (PGN-S-monomer) to extracellular domain (ECD-TLR-2) of the unbound TLR-2. Quantification, in silico, of free energy of binding (DG) identified 2 close sites for peptides and PGN. The PGN-S-monomer binding site is between amino acids TLR-2, 404-430 or more closely TLR-2, 417-428. The peptide-binding site is between amino acids TLR-2, 434-455. Molecular models show PGN-S-monomer inserts its N -acetyl-glucosamine (NAG) deep in the TLR-2 coil, while its terminal lysine interacts with inside (Glu(403)) and outside pocket (Tyr(378)). Peptides insert their two N -terminal arginines or their C-terminal tyrosines in the TLR-2 coil. PGN did not bind the lipopeptide-binding site in the TLR-2. It can bind the C-terminus, 572-586 (DG = 0.026 kcal), of "lipopeptide-bound" TLR-2. An additional, low-affinity PGN-binding site is TLR-2 (227-237). MTP, MDP, and lysine-less PGN bind to TLR-2, 87-113. This is the first report identifying candidate binding sites of monomer PGN and peptides on TLR-2. Experimental verification of our findings is needed to create synthetic adjuvant for vaccines. Such synthetic PGN can direct both adjuvant and cancer antigen to TLR-2.
Insights
Novel peptides can block bacterial cell wall components from activating Toll-like receptor 2 (TLR-2). This discovery in molecular modeling could lead to new vaccine adjuvants and cancer therapies by targeting TLR-2 signaling.
Area of Science:
- Immunology
- Molecular Biology
- Structural Biology
Background:
- Bacterial cell wall polysaccharides, like peptidoglycan (PGN), activate monocytes/macrophages via receptors such as Toll-like receptor 2 (TLR-2).
- TLR-2 recognizes various ligands, including lipopeptides and bacterial glycoproteins, but specific binding sites for soluble PGN remain undefined.
- Peptides encountered in vivo may pre-form TLR-2, influencing its response to activators.
Purpose of the Study:
- To identify potential binding sites for peptides and monomeric PGN on the extracellular domain (ECD) of TLR-2.
- To understand the molecular interactions between these peptides, PGN, and TLR-2.
- To lay the groundwork for developing synthetic adjuvants for vaccines and cancer therapies.
Main Methods:
- In silico molecular docking of peptides and PGN monomer (PGN-S-monomer) to the ECD of TLR-2.
- Computational quantification of binding free energy (DG) to identify candidate binding sites.
- Analysis of molecular models to visualize insertion and interaction of PGN and peptides within TLR-2.
Main Results:
- Two distinct binding sites were identified for peptides and PGN on TLR-2.
- The PGN-S-monomer binds to TLR-2 residues 404-430 (most closely 417-428), with N-acetyl-glucosamine (NAG) inserting deeply and lysine interacting with Glu(403) and Tyr(378).
- Peptides bind to TLR-2 residues 434-455, with N-terminal arginines or C-terminal tyrosines interacting with the TLR-2 coil. PGN also shows low-affinity binding at other sites, distinct from the lipopeptide site.
Conclusions:
- This study presents the first identification of candidate binding sites for monomeric PGN and specific peptides on TLR-2.
- The findings suggest that peptides can interfere with PGN binding and activation of TLR-2.
- Experimental validation is crucial for developing synthetic PGN-based adjuvants that can target both adjuvant and cancer antigens to TLR-2.
More Related Videos
Related Concept Videos
Peptidoglycan Synthesis
Formation of Lipopolysaccharides
Inhibitors of Gram-positive Cell Wall Synthesis
Protein Folding Quality Check in the RER
Peptide Bonds
Protein Modifications in the RER
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.

